Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Information Storage and Retrieval | 1 | 2018 | 644 | 0.48 | Why? |
| Palliative Care | 1 | 2018 | 2665 | 0.25 | Why? |
| Bias | 6 | 2021 | 1109 | 0.22 | Why? |
| Gene-Environment Interaction | 1 | 2020 | 127 | 0.19 | Why? |
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2018 | 64 | 0.18 | Why? |
| Rickettsia Infections | 1 | 2018 | 58 | 0.18 | Why? |
| Point-of-Care Systems | 2 | 2021 | 2955 | 0.16 | Why? |
| Symptom Assessment | 2 | 2021 | 4967 | 0.16 | Why? |
| Ultrasonography | 3 | 2021 | 4409 | 0.15 | Why? |
| Pneumococcal Vaccines | 2 | 2018 | 571 | 0.15 | Why? |
| Selection Bias | 3 | 2021 | 201 | 0.15 | Why? |
| Radiography, Thoracic | 3 | 2021 | 5486 | 0.15 | Why? |
| Pneumococcal Infections | 2 | 2018 | 562 | 0.14 | Why? |
| Review Literature as Topic | 1 | 2018 | 387 | 0.14 | Why? |
| Ambulatory Care | 2 | 2021 | 4947 | 0.13 | Why? |
| Reference Standards | 3 | 2021 | 1163 | 0.12 | Why? |
| Models, Organizational | 1 | 2018 | 908 | 0.12 | Why? |
| Primary Health Care | 2 | 2021 | 4839 | 0.12 | Why? |
| False Positive Reactions | 3 | 2021 | 1338 | 0.11 | Why? |
| Tuberculosis | 2 | 2017 | 2895 | 0.11 | Why? |
| Transients and Migrants | 3 | 2018 | 1468 | 0.11 | Why? |
| False Negative Reactions | 3 | 2021 | 1785 | 0.10 | Why? |
| Minority Groups | 1 | 2020 | 1631 | 0.09 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.09 | Why? |
| Arthralgia | 2 | 2021 | 173 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Sensitivity and Specificity | 7 | 2021 | 22971 | 0.09 | Why? |
| Fever | 3 | 2021 | 7795 | 0.08 | Why? |
| Health Education | 1 | 2018 | 1539 | 0.08 | Why? |
| Antigens, Viral | 2 | 2021 | 6298 | 0.08 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.07 | Why? |
| Outpatient Clinics, Hospital | 2 | 2021 | 523 | 0.07 | Why? |
| Myalgia | 2 | 2021 | 1015 | 0.07 | Why? |
| Immunocompromised Host | 2 | 2018 | 5150 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2021 | 4239 | 0.07 | Why? |
| Physical Examination | 2 | 2021 | 755 | 0.07 | Why? |
| Drug Users | 2 | 2018 | 234 | 0.07 | Why? |
| North America | 2 | 2020 | 1400 | 0.07 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.06 | Why? |
| Immunogenicity, Vaccine | 1 | 2018 | 4624 | 0.06 | Why? |
| Homeless Persons | 3 | 2018 | 1171 | 0.06 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.05 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.05 | Why? |
| Headache | 2 | 2021 | 2257 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.05 | Why? |
| Fatigue | 2 | 2021 | 2479 | 0.05 | Why? |
| Boutonneuse Fever | 1 | 2018 | 21 | 0.05 | Why? |
| Spotted Fever Group Rickettsiosis | 1 | 2018 | 11 | 0.05 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.05 | Why? |
| Creatine Kinase | 1 | 2020 | 386 | 0.05 | Why? |
| Confidence Intervals | 1 | 2021 | 744 | 0.04 | Why? |
| Arthropod Vectors | 1 | 2018 | 35 | 0.04 | Why? |
| Transplantation | 1 | 2018 | 72 | 0.04 | Why? |
| Reference Values | 1 | 2020 | 795 | 0.04 | Why? |
| Rickettsia | 1 | 2018 | 101 | 0.04 | Why? |
| Azathioprine | 1 | 2018 | 161 | 0.04 | Why? |
| Scrub Typhus | 1 | 2018 | 68 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.04 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.04 | Why? |
| Antibody Specificity | 1 | 2020 | 1328 | 0.04 | Why? |
| Necrosis | 1 | 2018 | 532 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.03 | Why? |
| Platelet Count | 1 | 2020 | 1381 | 0.03 | Why? |
| Creatinine | 1 | 2020 | 1443 | 0.03 | Why? |
| Peer Group | 1 | 2018 | 402 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.03 | Why? |
| Child | 5 | 2021 | 70012 | 0.03 | Why? |
| Liver Function Tests | 1 | 2020 | 1325 | 0.03 | Why? |
| Sex Workers | 1 | 2018 | 348 | 0.03 | Why? |
| Community Health Workers | 1 | 2018 | 468 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.03 | Why? |
| European Union | 1 | 2017 | 565 | 0.03 | Why? |
| Humans | 18 | 2021 | 930598 | 0.03 | Why? |
| L-Lactate Dehydrogenase | 1 | 2020 | 1995 | 0.03 | Why? |
| Europe | 2 | 2020 | 12702 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.03 | Why? |
| Mobile Health Units | 1 | 2018 | 741 | 0.03 | Why? |
| Leukocyte Count | 1 | 2020 | 3178 | 0.03 | Why? |
| Rituximab | 1 | 2018 | 1096 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2018 | 1357 | 0.03 | Why? |
| Prisoners | 1 | 2018 | 738 | 0.02 | Why? |
| Israel | 1 | 2018 | 2751 | 0.02 | Why? |
| Africa | 1 | 2018 | 2986 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2020 | 5440 | 0.02 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Social Stigma | 1 | 2017 | 1049 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Lung | 3 | 2021 | 31049 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Cough | 1 | 2021 | 4891 | 0.02 | Why? |
| Motivation | 1 | 2017 | 1640 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2021 | 9537 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Autoimmune Diseases | 1 | 2018 | 1996 | 0.02 | Why? |
| Qualitative Research | 1 | 2017 | 4337 | 0.02 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.02 | Why? |
| Family | 1 | 2017 | 2909 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| HIV Infections | 2 | 2018 | 11620 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Young Adult | 1 | 2021 | 93724 | 0.01 | Why? |
| Risk Factors | 1 | 2018 | 71621 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
| Male | 2 | 2018 | 367725 | 0.01 | Why? |
| Female | 2 | 2018 | 380317 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |